MAXIMUS, Inc. (NYSE:MMS) has been given a consensus recommendation of “Hold” by the eight research firms that are covering the firm, MarketBeat.com reports. One analyst has rated the stock with a sell recommendation, five have issued a hold recommendation and one has issued a buy recommendation on the company. The average twelve-month price target among brokers that have issued a report on the stock in the last year is $67.25.
Several research analysts have weighed in on MMS shares. Canaccord Genuity reaffirmed a “buy” rating on shares of MAXIMUS in a research report on Wednesday, December 27th. Zacks Investment Research raised MAXIMUS from a “hold” rating to a “buy” rating and set a $71.00 target price on the stock in a research report on Tuesday. Finally, Maxim Group reaffirmed a “hold” rating and issued a $69.00 target price (up from $66.00) on shares of MAXIMUS in a research report on Thursday, February 8th.
MAXIMUS (NYSE:MMS) traded up $0.72 during trading hours on Friday, reaching $67.26. The company had a trading volume of 846,812 shares, compared to its average volume of 559,623. The firm has a market capitalization of $4,380.00, a price-to-earnings ratio of 21.02, a price-to-earnings-growth ratio of 2.21 and a beta of 1.21. MAXIMUS has a 52-week low of $57.12 and a 52-week high of $72.71. The company has a quick ratio of 2.57, a current ratio of 2.57 and a debt-to-equity ratio of 0.01.
MAXIMUS (NYSE:MMS) last posted its quarterly earnings results on Thursday, February 8th. The health services provider reported $0.78 earnings per share for the quarter, beating the consensus estimate of $0.77 by $0.01. The firm had revenue of $623.10 million for the quarter, compared to analyst estimates of $624.36 million. MAXIMUS had a return on equity of 22.93% and a net margin of 8.99%. MAXIMUS’s quarterly revenue was up 2.6% on a year-over-year basis. During the same period in the previous year, the firm earned $0.71 earnings per share. sell-side analysts anticipate that MAXIMUS will post 3.44 earnings per share for the current year.
The company also recently announced a quarterly dividend, which will be paid on Wednesday, February 28th. Shareholders of record on Thursday, February 15th will be given a $0.045 dividend. This represents a $0.18 annualized dividend and a yield of 0.27%. The ex-dividend date is Wednesday, February 14th. MAXIMUS’s payout ratio is currently 5.63%.
In other news, CEO Richard A. Montoni sold 30,000 shares of the stock in a transaction dated Thursday, December 7th. The stock was sold at an average price of $69.25, for a total transaction of $2,077,500.00. The sale was disclosed in a document filed with the SEC, which is available at this link. Also, General Counsel David Francis sold 3,600 shares of the stock in a transaction dated Tuesday, February 13th. The shares were sold at an average price of $64.50, for a total value of $232,200.00. Following the transaction, the general counsel now directly owns 10,017 shares in the company, valued at approximately $646,096.50. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 68,244 shares of company stock worth $4,699,326. Insiders own 3.10% of the company’s stock.
Hedge funds and other institutional investors have recently modified their holdings of the company. Amundi Pioneer Asset Management Inc. acquired a new position in shares of MAXIMUS during the 4th quarter valued at about $163,000. Steward Partners Investment Advisory LLC acquired a new position in shares of MAXIMUS during the 4th quarter valued at about $169,000. Capital One National Association acquired a new position in shares of MAXIMUS during the 4th quarter valued at about $213,000. Zeke Capital Advisors LLC acquired a new position in shares of MAXIMUS during the 4th quarter valued at about $222,000. Finally, Intl Fcstone Inc. acquired a new position in shares of MAXIMUS during the 2nd quarter valued at about $201,000. 95.55% of the stock is currently owned by institutional investors and hedge funds.
COPYRIGHT VIOLATION WARNING: This news story was originally published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this news story on another publication, it was illegally stolen and reposted in violation of United States and international copyright & trademark law. The correct version of this news story can be viewed at https://www.dispatchtribunal.com/2018/02/18/analysts-set-maximus-inc-mms-price-target-at-66-00.html.
MAXIMUS Company Profile
MAXIMUS, Inc provides business process services (BPS) to government health and human services agencies. The Company operates through three segments: U.S. Federal Services, Health Services and Human Services. The U.S. Federal Services segment provides BPS and program management for large government programs, independent health review and appeals services for both the United States Federal Government, and state-based programs and technology solutions for civilian federal programs.
Receive News & Ratings for MAXIMUS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MAXIMUS and related companies with MarketBeat.com's FREE daily email newsletter.